TOP TIERMARKET NEWSWIRE

News & sentiment

DISC MEDICINE INC (IRON) — News & AI sentiment

DISC MEDICINE INC (IRON) news roundup. 7 stories in the past week, 14 over 30 days. Average 30-day sentiment is 54.1/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 14 sales totalling $15.9M — net selling of $15.9M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

0

7d stories

7

avg sentiment 58.3/100

30d stories

14

avg sentiment 54.1/100

Insider net (90d)

$15.9M

0 buys · 14 sells

Congress (90d)

0

0 buys · 0 sells

IRON news in the last 24 hours, 7 days, 30 days and 90 days

How much IRON coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time window	IRON stories	Avg AI sentiment	Read
Last 24 hours	0	—	no coverage
Last 7 days	7	58.3/100	IRON headlines →
Last 30 days	14	54.1/100	IRON headlines →
Last 90 days	34	51.2/100	IRON headlines →

Latest stories on IRON

Disc Medicine, Inc. (IRON) files 8-K

SEC 8-K50 · neutralgeneral

3d ago

H.C. Wainwright reiterates Disc Medicine stock rating on trial data

Investing.com Analyst Ratings56 · neutralanalyst

3d ago

Jefferies reiterates Disc Medicine stock rating on polycythemia data

Investing.com Analyst Ratings56 · neutralanalyst

3d ago

Disc Medicine stock rating held at Outperform by BMO on trial data

Investing.com Analyst Ratings61 · neutralanalyst

3d ago

Disc Medicine presents initial results from RESTORE phase 2 trial in PV patients

The Fly59 · neutralproduct/pr

4d ago

Disc Medicine Presents Initial Results from RESTORE-PV Phase 2 Trial in Patients with Polycythemia Vera (PV) at the 14th Society of Hematologic Oncology (SOHO) Annual Meeting

GlobeNewswire63 · neutralproduct/pr

4d ago

Disc Medicine Presents Initial Results from RESTORE-PV Phase 2 Trial in Patients with Polycythemia Vera (PV) at the 14th Society of Hematologic Oncology (SOHO) Annual Meeting

Business Insider63 · neutralproduct/pr

4d ago

Disc Medicine to Participate in Upcoming Investor Conferences

GlobeNewswire50 · neutralgeneral

Sep 2

Cantor Fitzgerald reiterates Disc Medicine stock rating on survey data

Investing.com Analyst Ratings50 · neutralanalyst

Sep 1

Disc Medicine Announces Multiple Presentations Across Portfolio at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting

Business Insider56 · neutralproduct/pr

Aug 31

Disc Medicine Announces Multiple Presentations Across Portfolio at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting

GlobeNewswire56 · neutralproduct/pr

Aug 31

ROSEN, A LONGSTANDING LAW FIRM, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON

Business Insider42 · neutralgeneral

Aug 23

Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON

Barchart34 · bearishgeneral

Aug 22

Disc Medicine price target raised to $90 from $85 at Morgan Stanley

The Fly61 · neutralanalyst

Aug 17

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Disc Medicine, Inc. Investors with Losses in Excess of $100K to Inquire About Securities Class Action Investigation - IRON

Business Insider34 · bearishgeneral

Aug 9

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON

Business Insider50 · neutralgeneral

Aug 8

Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON

Barchart48 · neutralgeneral

Aug 1

ROSEN, A LONGSTANDING FIRM, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON

Business Insider48 · neutralgeneral

Jul 31

Disc Medicine GAAP EPS of -$1.54 beats by $0.19

Seeking Alpha56 · neutralearnings

Jul 30

Disc Medicine, Inc. (IRON) files 8-K

SEC 8-K50 · neutralgeneral

Jul 30

Disc Medicine Reports Second Quarter 2026 Financial Results and Provides Business Update

StockTitan50 · neutralearnings

Jul 30

ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON

Business Insider48 · neutralgeneral

Jul 22

Going Deeper On Disc Medicine

Seeking Alpha58 · neutralgeneral

Jul 21

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON

Business Insider48 · neutralgeneral

Jul 12

ROSEN, A LEADING LAW FIRM, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON

Business Insider48 · neutralgeneral

Jul 10

Open IRON in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →